These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23478849)

  • 1. Atypical bisphosphonate-associated subtrochanteric and femoral shaft stress fractures: diagnostic features on bone scan.
    Probst S; Rakheja R; Stern J
    Clin Nucl Med; 2013 May; 38(5):397-9. PubMed ID: 23478849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotomous location of 160 atypical femoral fractures.
    Koeppen VA; Schilcher J; Aspenberg P
    Acta Orthop; 2013 Dec; 84(6):561-4. PubMed ID: 24286566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography.
    Rosenberg ZS; La Rocca Vieira R; Chan SS; Babb J; Akyol Y; Rybak LD; Moore S; Bencardino JT; Peck V; Tejwani NC; Egol KA
    AJR Am J Roentgenol; 2011 Oct; 197(4):954-60. PubMed ID: 21940585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
    Lee SH; Lee YH; Suh JS
    AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral fracture and temporomandibular joint destruction following the use of bisphosphonates.
    Skoglund K; Hjortdal O
    Tidsskr Nor Laegeforen; 2015 Jan; 135(2):116-7. PubMed ID: 25625987
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
    Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
    J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.
    Park-Wyllie LY; Mamdani MM; Juurlink DN; Hawker GA; Gunraj N; Austin PC; Whelan DB; Weiler PJ; Laupacis A
    JAMA; 2011 Feb; 305(8):783-9. PubMed ID: 21343577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtrochanteric stress fractures in patients on oral bisphosphonate therapy: an emerging problem.
    Murphy CG; O'Flanagan S; Keogh P; Kenny P
    Acta Orthop Belg; 2011 Oct; 77(5):632-7. PubMed ID: 22187839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate use and atypical fractures of the femoral shaft.
    Schilcher J; Michaëlsson K; Aspenberg P
    N Engl J Med; 2011 May; 364(18):1728-37. PubMed ID: 21542743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl.
    Boyce AM; Collins MT; Tosi LL; Gafni RI
    Horm Res Paediatr; 2017; 87(1):69-72. PubMed ID: 27379824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?
    Koh JS; Goh SK; Png MA; Kwek EB; Howe TS
    J Orthop Trauma; 2010 Feb; 24(2):75-81. PubMed ID: 20101130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of atypical femoral fracture].
    Iwata K; Mashiba T
    Clin Calcium; 2016 Jan; 26(1):73-9. PubMed ID: 26728533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs of Insufficiency Fractures Overlooked in a Patient Receiving Chronic Bisphosphonate Therapy.
    Shaikh W; Morris D; Morris S
    J Am Board Fam Med; 2016; 29(3):404-7. PubMed ID: 27170798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical subtrochanteric fractures, bisphosphonates, blinded radiological review.
    Warren C; Gilchrist N; Coates M; Frampton C; Helmore J; McKie J; Hooper G
    ANZ J Surg; 2012 Dec; 82(12):908-12. PubMed ID: 22943522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
    Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
    Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic bilateral intramedullary femoral nails for bisphosphonate-associated signs of impending subtrochanteric hip fracture.
    Yoon RS; Beebe KS; Benevenia J
    Orthopedics; 2010 Apr; 33(4):. PubMed ID: 20415309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent bisphosphonate-related bilateral atypical subtrochanteric fractures and osteonecrosis of the jaw on bone scintigraphy.
    Kim JE; Yun M; Lim SK; Rhee Y
    Clin Nucl Med; 2015 May; 40(5):450-2. PubMed ID: 25706787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Adams AL; Xue F; Chantra JQ; Dell RM; Ott SM; Silverman S; Giaconi JC; Critchlow C
    Osteoporos Int; 2017 Jan; 28(1):413-417. PubMed ID: 27766369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy.
    Teo BJ; Koh JS; Goh SK; Png MA; Chua DT; Howe TS
    Bone Joint J; 2014 May; 96-B(5):658-64. PubMed ID: 24788502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.